These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3260074)

  • 21. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
    Hubbard RC; Sellers S; Czerski D; Stephens L; Crystal RG
    JAMA; 1988 Sep; 260(9):1259-64. PubMed ID: 3261353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?].
    Johansen S; Gulsvik A
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2142-5. PubMed ID: 2788939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The variability of clinical presentation of chronic obstructive pulmonary disease in patients with hereditary alpha-1 antitrypsin deficiency].
    Kuca P; Kamiński D; Campbell E; Kołakowski J; Goljan-Geremek A; Puścińska E; Bieleń P; Nowiński A; Wojda E; Hawryłkiewicz I; Sliwiński P; Górecka D
    Pneumonol Alergol Pol; 2004; 72(9-10):420-3. PubMed ID: 16021998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative biochemical efficacy analysis of an alpha
    Li Z; Franke RM; Morris D; Yel L
    Pulm Pharmacol Ther; 2022 Jun; 73-74():102124. PubMed ID: 35314325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients.
    King MB; Campbell EJ; Gray BH; Hertz MI
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):966-71. PubMed ID: 8143063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary disease in alpha-1-antitrypsin deficiency.
    Snider GL
    Ann Intern Med; 1989 Dec; 111(12):957-9. PubMed ID: 2688506
    [No Abstract]   [Full Text] [Related]  

  • 28. [Substitution therapy with alpha-1-Pi in patients with alpha-1-Pi deficiency and progressive pulmonary edema].
    Konietzko N; Becker M; Schmidt EW; Rasche B; Ulmer WT; Ferlinz R; Lorenz J
    Dtsch Med Wochenschr; 1988 Mar; 113(10):369-73. PubMed ID: 3280283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic half-life and organ distribution of radiolabeled human PiM and PiZ alpha-1-antitrypsin in the dog.
    Moser KM; Kidikoro Y; Marsh J; Sgroi V
    J Lab Clin Med; 1978 Feb; 91(2):214-22. PubMed ID: 304468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha1-antitrypsin review.
    Stockley RA
    Clin Chest Med; 2014 Mar; 35(1):39-50. PubMed ID: 24507836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-1-antitrypsin deficiency.
    Idell S; Cohen AB
    Clin Chest Med; 1983 Sep; 4(3):359-75. PubMed ID: 6357600
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.
    Weitz JI; Silverman EK; Thong B; Campbell EJ
    J Clin Invest; 1992 Mar; 89(3):766-73. PubMed ID: 1541671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M
    Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients.
    Constans J; Carles P; Boneu A; Arnaud J; Tufenkji AE; Pujazon MC; Tavera C
    Clin Pharmacokinet; 1992 Aug; 23(2):161-8. PubMed ID: 1511530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of pulmonary emphysema in an alpha-1 proteinase inhibitor-deficient lung transplant recipient.
    Mal H; Guignabert C; Thabut G; d'Ortho MP; Brugière O; Dauriat G; Marrash-Chahla R; Rangheard AS; Lesèche G; Fournier M
    Am J Respir Crit Care Med; 2004 Oct; 170(7):811-4. PubMed ID: 15184198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group.
    Gottlieb DJ; Luisetti M; Stone PJ; Allegra L; Cantey-Kiser JM; Grassi C; Snider GL
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2069-72. PubMed ID: 11112116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells.
    Ross D; Brown T; Harper R; Pamarthi M; Nixon J; Bromirski J; Li CM; Ghali R; Xie H; Medvedeff G; Li H; Scuderi P; Arora V; Hunt J; Barnett T
    J Biotechnol; 2012 Dec; 162(2-3):262-73. PubMed ID: 23036927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
    Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha 1-proteinase inhibitor for alpha 1-antitrypsin deficiency.
    Med Lett Drugs Ther; 1988 Mar; 30(761):29-30. PubMed ID: 3257810
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
    Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
    Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.